Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2017-03-20 2017-03-14
Drug Identification Number 02240695 02240695
Brand name INTRON A INTRON A
Common or Proper name INTERFERON ALFA-2b solution pour injection INTERFERON ALFA-2b solution pour injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients INTERFERON ALFA-2B INTERFERON ALFA-2B
Strength(s) 50000000UNIT 50000000UNIT
Dosage form(s) LIQUID LIQUID
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1.2 mL - 60 x 10 6 IU/pen - 60 x 10 6 UI/stylo 1.2 mL - 60 x 10 6 IU/pen - 60 x 10 6 UI/stylo
ATC code L03AB L03AB
ATC description IMMUNOSTIMULANTS IMMUNOSTIMULANTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-02-09 2017-02-09
Actual start date 2017-03-09 2017-03-09
Estimated end date 2017-03-17 2017-03-17
Actual end date 2017-03-20
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Limited quantities available Quantités limitées disponibles / Limited quantities available
Health Canada comments